Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetes
Top Cited Papers
- 2 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Genetics
- Vol. 52 (5), 473-481
- https://doi.org/10.1038/s41588-020-0615-4
Abstract
Here we report biallelic mutations in the sorbitol dehydrogenase gene (SORD) as the most frequent recessive form of hereditary neuropathy. We identified 45 individuals from 38 families across multiple ancestries carrying the nonsense c.757delG (p.Ala253GlnfsTer27) variant in SORD, in either a homozygous or compound heterozygous state. SORD is an enzyme that converts sorbitol into fructose in the two-step polyol pathway previously implicated in diabetic neuropathy. In patient-derived fibroblasts, we found a complete loss of SORD protein and increased intracellular sorbitol. Furthermore, the serum fasting sorbitol levels in patients were dramatically increased. In Drosophila, loss of SORD orthologs caused synaptic degeneration and progressive motor impairment. Reducing the polyol influx by treatment with aldose reductase inhibitors normalized intracellular sorbitol levels in patient-derived fibroblasts and in Drosophila, and also dramatically ameliorated motor and eye phenotypes. Together, these findings establish a novel and potentially treatable cause of neuropathy and may contribute to a better understanding of the pathophysiology of diabetes.Keywords
This publication has 42 references indexed in Scilit:
- Inhibition of sorbitol dehydrogenase by nucleosides and nucleotidesBiochemical and Biophysical Research Communications, 2013
- An empirical estimate of carrier frequencies for 400+ causal Mendelian variants: results from an ethnically diverse clinical sample of 23,453 individualsGenetics in Medicine, 2013
- The Drosophila Gene Disruption Project: Progress Using Transposons With Distinctive Site SpecificitiesGenetics, 2011
- The induction of trehalose and glycerol in Saccharomyces cerevisiae in response to various stressesBiochemical and Biophysical Research Communications, 2009
- Aldose reductase inhibitors for the treatment of diabetic polyneuropathyCochrane Database of Systematic Reviews, 2007
- The Polyol Pathway as a Mechanism for Diabetic Retinopathy: Attractive, Elusive, and ResilientExperimental Diabetes Research, 2007
- A potent sorbitol dehydrogenase inhibitor exacerbates sympathetic autonomic neuropathy in rats with streptozotocin-induced diabetesExperimental Neurology, 2005
- Sorbitol Dehydrogenase of DrosophilaPublished by Elsevier BV ,1998
- Deletion of the steroid 21-hydroxylase and complement C4 genes in congenital adrenal hyperplasia.Journal of Medical Genetics, 1986
- Sorbitol dehydrogenase genetics in the mouse: A ‘;null’ mutant in a ‘;European’ C57BL strainAnimal Blood Groups and Biochemical Genetics, 1982